← Leaderboards
Bridgett Burman
Dynport Vaccine Company, Llc
$31,982
Attributed
$31,982
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$31,982 · 1
By mechanism
N01$31,982 · 1
Top collaborators
No co-investigators on record.
Most similar at Dynport Vaccine Company, Llc
Same institution · by research overlap
- Graig Shockey$9,887,057
- Salama Balume$16,877,312
- David Shumway$6,214,596
- George Saviolakis$1,316,543
- Casey Long$2,265,501
Others in their field
Other Rising Stars on “Antibiotic Resistant Infections”
- Andrew Tomaras · Forge Therapeutics, Inc.$10,977,909
- Urs Oschner · Crestone, Inc.$8,499,692
- Ralf Lenigk · Ge Medical Systems Information Technologies, Inc$4,211,973
- Laurene Wang · Aimmax Therapeutics, Inc.$3,663,308
- Brian Kane · Spero Therapeutics, Inc.$3,424,537
- Todd Wallach · Oncosting Llc$3,261,288
Research focus
Antibiotic Resistant InfectionsClinical Trials UnitCombating Antibiotic Resistant BacteriaGram-Positive BacteriaImmune Modulating AgentsInfectious Disease TreatmentInvestigationNovel TherapeuticsPhase I Clinical TrialsTherapeutic Agents